Outcome of the Board Meeting under Regulations 30 & 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended ('SEBI Listing Regulations').
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sai Capital Ltd's Board approved its Q1 FY26 (quarter ended June 30, 2025) unaudited financial results. On a standalone basis, the company had zero revenue and posted a loss of ₹15.24 lakh, with employee and finance costs as the main expenses. On a consolidated basis, however, the picture was much stronger: total income rose to ₹599.58 lakh (up ~31% from ₹455.84 lakh a year ago), driven mainly by other income of ₹584.83 lakh, while net profit jumped to ₹311.28 lakh (up ~66% from ₹187.87 lakh). The consolidated EPS stood at ₹10.81. The Board also fixed the 30th AGM for September 29, 2025, and approved the re-appointment of Mrs. Kamlesh Gupta as Independent Director and Ms. Sakshi Gupta as Secretarial Auditor for five-year terms.
The value for shareholders sits in the subsidiaries (Health Care Energy Foods and its units) – the listed entity on its own is a loss-making shell with no operations. Consolidated profit growth of nearly 66% YoY is a positive signal, but investors should be aware that earnings are heavily concentrated in 'other income' rather than core operations.